Fidaxomicin: Completed Phase III enrollment

Optimer completed enrollment of 536 patients in a double-blind, international Phase III trial comparing 200 mg of oral fidaxomicin given twice daily vs. 125 mg of oral vancomycin given 4 times daily f...